The usual cause for the fund is to invest in rounds with 4 partakers. Despite the Puissance Capital, startups are often financed by Xeraya Capital, OrbiMed, Kearny Venture Partners. The meaningful sponsors for the fund in investment in the same round are OrbiMed, Kearny Venture Partners, Acuta Capital Partners.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2015. The top activity for fund was in 2017. The fund is constantly included in less than 2 deals per year.
Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight ViewRay.
Related Funds
Fund Name | Location |
eBay Enterprise | King Of Prussia, Pennsylvania, United States |
Huatai Securities Co., Ltd. | China, Jiangsu, Nanjing |
Jintuo Capital | Beijing, Beijing, China |
Juyuan Incubator | Chengdu, China, Sichuan |
NEAR | California, San Francisco, United States |
Shiji Group | Beijing, Beijing, China |
Startup Angels Network | Gurgaon, Haryana, India |
TPM GunClear, LLC | - |
Xizang Taifu | Chengguan District, China, Lhasa |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.